Cite
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy
MLA
Doriana Vaddinelli, et al. “Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.” Chemotherapy, vol. 64, Jan. 2019, pp. 110–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6df24893931afd4c8aaade1eb46f0c8f&authtype=sso&custid=ns315887.
APA
Doriana Vaddinelli, Giuseppe Milone, Alessandra Cupri, Anna Bulla, Concetta Conticello, Angelo Curto Pelle, Giulio Antonio Milone, Valerio Leotta, Uros Markovic, Enrica Antonia Martino, Mary Ann Di Giorgio, Loredana Villari, Giuseppe Sapienza, Maria Cristina Pirosa, Salvatore Leotta, & Luca Scalise. (2019). Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy. Chemotherapy, 64, 110–114.
Chicago
Doriana Vaddinelli, Giuseppe Milone, Alessandra Cupri, Anna Bulla, Concetta Conticello, Angelo Curto Pelle, Giulio Antonio Milone, et al. 2019. “Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.” Chemotherapy 64 (January): 110–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6df24893931afd4c8aaade1eb46f0c8f&authtype=sso&custid=ns315887.